Bruker has announced the planned discontinuation of the IsoSpark and IsoLight platforms. Customers with questions about transition options and last-time-buy opportunities should contact their Bruker sales representative.
In this Webinar we discuss:
How understanding the functional mechanism may play a role in interrupting severe pulmonary manifestations
Therapeutic strategies to overcome pathogenesis of severe inflammation
How testing and diagnosis of the immune response to infectious disease will play a role